Signoriello E, Lus G, Bonavita S, Lanzillo R, et al. Switch from sequestering to anti-CD20 depleting treatment: disease activity outcomes during wash-out and in the first 6 months of ocrelizumab therapy. Mult Scler 2022;28:93-101.
PMID: 33855897